Robert Goecker
Foot & Ankle Surgery · Winston Salem, NCNPI 1538128020
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,425 of the $11,377 with a category attached, or 82.8%. Organogenesis Inc. accounts for 92.5% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $7,906 and has fallen 98.7% since, to $103 in 2025.
Across 60 payments — averaging $189.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$11K
- Smith+Nephew$178
- Stryker$167
- Cardiovascular Systems Inc.$87
- Arthrosurface Incorporated$66
- KCI USA, Inc.$59
- plus $293 from 12 others
What the payments were for
- Speaking & faculty fees$9,42583%
- Travel & lodging$7987%
- Food & beverage$1,15310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 25 | $10,527 |
| Smith+Nephew | 7 | $178 |
| Stryker(2 entities) | 5 | $167 |
| Cardiovascular Systems Inc. | 1 | $87 |
| Arthrosurface Incorporated | 4 | $66 |
| KCI USA, Inc. | 3 | $59 |
| Kerecis Limited | 2 | $52 |
| Biocomposites Inc | 3 | $45 |
| Boston Scientific | 1 | $27 |
| OVIK Health, LLC | 1 | $26 |
| AbbVie | 1 | $22 |
| Melinta Therapeutics, LLC | 1 | $22 |
| Orthofix Medical, Inc. | 1 | $18 |
| Solventum Corporation | 1 | $18 |
| Lifenet Health | 1 | $17 |
| Amgen | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $16 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$8,403
- Dermagraft$6,626
- Puraply/Affinity/NuTech$6,626
- Affinity$2,300
- PURAPLY WOUND MATRIX$1,300
- NOVACHOR$1,300
- NuShield$1,300
- PuraPly$800
How this compares
$11,377 in reported general payments places this provider in the 85th percentile of 196 foot & ankle surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $4,857 |
| Terbinafine Hcl | 131 | $3,402 |
| Ciclopirox | 53 | $1,854 |
| Gabapentin | 88 | $1,117 |
| Ammonium Lactate | 27 | $896 |
| Mupirocin | 60 | $509 |
| Doxycycline Monohydrate | 23 | $387 |
| Clindamycin Hcl | 22 | $327 |
| Fluconazole | 13 | $270 |
| CiclopiroxCiclopirox Olamine | 11 | $257 |
| Celecoxib | 21 | $229 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $198 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $194 |
| Allopurinol | 23 | $165 |
| Cephalexin | 24 | $165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $178 | $4,85712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 196 foot & ankle surgery providers in North Carolina.
Other foot & ankle surgery in Winston Salem
- John BonvillianWinston Salem$11K
- Devon NiewohnerWinston Salem$10K
- Timothy VoglerWinston Salem$9K
- Robert OlsonGastonia$473K
- Austin MatthewsLumberton$279K
- Matthew DzurikWilmington$142K
- Kristen McGinnessFayetteville$123K
- William RespessGreenville$79K
- Brian FutrellCary$71K
- Kenneth BloomMooresville$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.